RYZNEUTA 20 mg/mL
efbemalenograstim alfa-vuxw · INJECTION · Acrotech Biopharma Inc
RYZNEUTA is a injection containing efbemalenograstim alfa-vuxw at 20 mg/mL, taken subcutaneous. Manufactured by Acrotech Biopharma Inc.
Key Facts
- Brand Name
- RYZNEUTA
- Generic Name
- efbemalenograstim alfa-vuxw
- NDC Code (Product)
72893-016- Manufacturer
- Acrotech Biopharma Inc
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761134
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 11/23/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is RYZNEUTA used for?
RYZNEUTA contains efbemalenograstim alfa-vuxw. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is RYZNEUTA a controlled substance?
RYZNEUTA is not classified as a controlled substance by the DEA.
What is the generic name for RYZNEUTA?
The generic name for RYZNEUTA is efbemalenograstim alfa-vuxw. There are no other listed brand versions of efbemalenograstim alfa-vuxw.
What is the NDC code for RYZNEUTA 20 mg/mL?
The NDC (National Drug Code) for RYZNEUTA 20 mg/mL is 72893-016, listed by Acrotech Biopharma Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)